Effect of the Tiaobufeishen decoction on Caveolin-1-p38 MAPK signaling pathway and mechanism of improving the tracheobronchomalacia in chronic obstructive pulmonary disease

摘要

cqvip:Objective: Reliving the rela ti onship of the Caveolin-1-p38 MAPK signaling pathway and COPD tr acheob ronchomalacia, and resea rch the mechanism of Tiaobufeishen decoc tion imp rove the regression of the weasand cartilage cells. Methods: Flow cytometry was used to analyze the apoptosis rate to determine the optimal concentration of Tiaobufeishen decoction and CSE, CCK8 assay was used to dete rmine the op ti mal concent ration of P38-MAPK specific inhibitor. The COPD cell model was created by tracheal chondrocyte which dispose by optimal concent ration CSE, then add the IL-1P set up the chond rocyte degene ration model, use the method of toluidine blue staining and immunohistochemical authenticate degeneration of cartilage. This research included control group, model group, model-Tiaobufeishen group, model-blocker group. When the model was set up succeed, add the Tiaobufeishen decoction and P38-MAPK blocke r in the model-Tiaobufeishen and model-blocke r gr oups, r espectively. Weste rn Blot was used to detect the exp ression of caveolin-1 and p-p38 in the chond rocyte. RT-PCR was used to detect the expression of MMP3 and caveolin-1 in the matrix. Results: The cell activity was not influence by the concentration of Tiaobufeishen decoction and blocker, the concentration of the CSE model was moderation. Compared with control group, the level of caveolin-1, p38MAPK, MMP3 in the model group was significant increase, moreover, the result of toluidine blue staining and immunohistochemical methods show that the chond rocyte has obvious reg ression. The exp ression of caveolin-1, p38MAPK, and MMP3 have significant decrease than the control group, and the reduction of chondrocyte degeneration. Conclusion: The caveolin-1-p38MAPK signaling pathway play an important role in the morbidity of the tracheobronchomalacia. Tiaobufeishen decoction could decrease the exp ression of the caveolin-1, p-p38, MMP3, inhibit the activa tion of the caveolin-1-p38MAPK signaling pathway, therefore, it can improve the tracheobronchomalacia.